US, EU, India, S.Africa reach compromise on Covid vaccine IP waiver text

The document authorises use of “patented subject matter required for the production and supply of Covid-19 vaccines without the consent of the right holder to the extent necessary to address the Covid-19 pandemic”.

The United States, European Union, India and South Africa have reached a consensus on key elements of a long-sought intellectual property waiver for Covid-19 vaccines, according to a proposed text reviewed by Reuters.